Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

COMy 2024

The 10th World Congress on Controversies in Multiple Myeloma

23–26 May 2024 | Paris, France / Online

The 10^th World Congress on Controversies in Multiple Myeloma (COMy) was held in Paris, France, and online between May 23-26, 2024, and brought together leading experts who shared the latest updates in the treatment and management of multiple myeloma.

View all videos

Addressing racial disparities in the treatment of multiple myeloma in America

Joseph Mikhael • 28 May 2024

Triplet regimens for treating multiple myeloma at early relapse

Joseph Mikhael • 28 May 2024

Selecting therapeutics for treating early relapses in multiple myeloma

Joseph Mikhael • 28 May 2024

The role of melflufen in the myeloma treatment landscape

Claudio Cerchione • 23 May 2024

Addressing racial disparities in the treatment of multiple myeloma in America

Joseph Mikhael • 28 May 2024

Triplet regimens for treating multiple myeloma at early relapse

Joseph Mikhael • 28 May 2024

The importance of risk-stratifying treatment for multiple and smoldering myeloma

Vincent Rajkumar • 25 May 2024

Biomarkers of microbiota dysbiosis to predict treatment response in hematologic malignancies

Florent Malard • 31 May 2024

Selecting therapeutics for treating early relapses in multiple myeloma

Joseph Mikhael • 28 May 2024

The role of melflufen in the myeloma treatment landscape

Claudio Cerchione • 23 May 2024

The patients’ perspective and advocacy in the fight against myeloma

Brian Durie • 24 May 2024

Manipulating the gut microbiome to change outcomes of multiple myeloma

Florent Malard • 31 May 2024